Prices delayed by at least 15 minutes | Print


Alliance Pharma PLC (APH)

ORD 1P
Sell: 38.8p|Buy: 39.2p|Change: 0.61 (-1.54%)

Open 

39.05p


Previous close 

39.5p


Trade high 

39.2p


Volume 

230,761


Year high 

73.04p


Year low 

33.70p


Dividend yield 

3%


Market capitalisation 

£210.17 mn


P/E ratio 

285.71


ISIN 

GB0031030819


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Share price

Dividends

PreviousLatest
Record date23/12/202223/06/2023
Ex-dividend date22/12/202222/06/2023
Payment date19/01/202318/07/2023
Amount0.59p1.18p

Performance 27/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Alliance Pharma PLC+ 0.89
FTSE AIM 100+ 0.44
More...

Company profile

Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
28/03/202410:40:0238.892211,1404,332.59
28/03/202410:26:1538.8519274.59
28/03/202410:26:1538.852,118822.84
28/03/202410:26:1538.854,5671,774.28
28/03/202410:26:1439.23,3831,326.14

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.